Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction

Reinhard Schneppenheim, Natalie Hellermann, Maria A. Brehm, Ulrike Klemm, Tobias Obser, Volker Huck, Stefan W. Schneider, Cécile V. Denis, Alexander Tischer, Matthew Auton, Winfried März, Emma-Ruoqi Xu, Matthias Wilmanns, Rainer B. Zotz

Blood (2019) 133 (4): 356–365.

https://doi.org/10.1182/blood-2018-04-843425

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

The Von Willebrand Factor Tyr2561 Allele Is a Gain-of-Function Variant and a Potential Risk Factor for Early Myocardial Infarction

Reinhard Schneppenheim, MD PhD, Natalie Hellermann, MD, Maria Alexandra Brehm, PhD, Ulrike Klemm, PhD, Tobias Obser, Volker Huck, PhD, Stefan W Schneider, Cecile V. Denis, PhD, Alexander Tischer, PhD, Matthew Auton, BSc, PhD, Winfried Maerz, MD, Emma-Ruoqi Xu, PhD, Matthias Wilmanns, PhD, Rainer B. Zotz

Blood (2018) 132 (Supplement 1): 2459.

https://doi.org/10.1182/blood-2018-99-116085

Published: 2018

Journal Articles

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MD, Aditi Shastri, MD

Blood (2018) 132 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2018-99-115613

Published: 2018

Journal Articles

Use of MGMT Resistance to Enrich for Transduced Hematopoietic Cells in Gene Therapy for Fabry Disease.

Natalia A. Pacienza, PhD, Nobuo Mizue, PhD, Matthew Scaife, BSc, Ronan Foley, MD, FRCPC, Jeffrey A. Medin, PhD

Blood (2009) 114 (22): 3584.

https://doi.org/10.1182/blood.V114.22.3584.3584

Published: 2009

Journal Articles

Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study

Anders Mälarstig, Alfonso Buil, Juan Carolos Souto, Robert Clarke, Francisco Blanco-Vaca, Jordi Fontcuberta, John Peden, Malin Andersen, Angela Silveira, Simona Barlera, Udo Seedorf, Hugh Watkins, Laura Almasy, Anders Hamsten, José Manuel Soria

Blood (2009) 114 (7): 1417–1422.

https://doi.org/10.1182/blood-2009-04-215269

Published: 2009

Includes: Supplemental data

Journal Articles

Factor V Leiden Is Associated with Premature Myocardial Infarction.

Flora Peyvandi, Marta Spreafico, Luisa Foco, Luisa Bernardinelli, Stefano Duga, Rosanna Asselta, Diego Ardissino, Sekar Kathiresan, Pierangelica Merlini, Pier M. Mannucci, MD

Blood (2008) 112 (11): 1817.

https://doi.org/10.1182/blood.V112.11.1817.1817

Published: 2008

Journal Articles

Bone Marrow Stem Cells Infusion in Treatment of Patients with Acute Myocardial Infarction.

Lidia Gil, PhD, Anna Czyz, PhD, Krzysztof Sawinski, PhD, Maria Kozlowska-Skrzypczak, PhD, Mieczyslaw Komarnicki, PhD, Stefan Grajek, PhD, Maciej Lesiak, PhD, Malgorzata Popiel, PhD, Piotr Breborowicz, PhD, Andrzej Cieslinski, PhD, Rafal Czepczynski, PhD, Jerzy Sowinski, PhD, Jan Styczynski, PhD

Blood (2006) 108 (11): 1682.

https://doi.org/10.1182/blood.V108.11.1682.1682

Published: 2006

Journal Articles

The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size

Jeffrey I. Zwicker, Flora Peyvandi, Roberta Palla, Rossana Lombardi, Maria Teresa Canciani, Andrea Cairo, Diego Ardissino, Luisa Bernardinelli, Kenneth A. Bauer, Jack Lawler, Pier Mannucci

Blood (2006) 108 (4): 1280–1283.

https://doi.org/10.1182/blood-2006-04-015701

Published: 2006

Journal Articles

A common polymorphism in the annexin V Kozak sequence (−1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

Rocio González-Conejero, Javier Corral, Vanessa Roldán, Constantino Martı́nez, Francisco Marı́n, José Rivera, Juan A. Iniesta, Marı́a L. Lozano, Pascual Marco, Vicente Vicente

Blood (2002) 100 (6): 2081–2086.

https://doi.org/10.1182/blood.V100.6.2081

Published: 2002

NARROW

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction

The Von Willebrand Factor Tyr2561 Allele Is a Gain-of-Function Variant and a Potential Risk Factor for Early Myocardial Infarction

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

Use of MGMT Resistance to Enrich for Transduced Hematopoietic Cells in Gene Therapy for Fabry Disease.

Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study

Factor V Leiden Is Associated with Premature Myocardial Infarction.

Bone Marrow Stem Cells Infusion in Treatment of Patients with Acute Myocardial Infarction.

The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size

A common polymorphism in the annexin V Kozak sequence (−1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only